nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C9—Capecitabine—esophageal cancer	0.0901	0.665	CbGbCtD
Fenofibrate—CYP2C9—Cisplatin—esophageal cancer	0.0454	0.335	CbGbCtD
Fenofibrate—Indomethacin—GLO1—esophageal cancer	0.0152	0.533	CrCbGaD
Fenofibrate—Clofibrate—CYP2A6—esophageal cancer	0.00557	0.195	CrCbGaD
Fenofibrate—Indomethacin—ABCC2—esophageal cancer	0.00305	0.107	CrCbGaD
Fenofibrate—Indomethacin—PTGS1—esophageal cancer	0.00231	0.0807	CrCbGaD
Fenofibrate—Blood creatinine increased—Cisplatin—esophageal cancer	0.00227	0.00476	CcSEcCtD
Fenofibrate—Oesophagitis—Capecitabine—esophageal cancer	0.00224	0.00472	CcSEcCtD
Fenofibrate—Ecchymosis—Capecitabine—esophageal cancer	0.00222	0.00467	CcSEcCtD
Fenofibrate—Cramp muscle—Cisplatin—esophageal cancer	0.00218	0.00458	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00218	0.00458	CcSEcCtD
Fenofibrate—Nasopharyngitis—Cisplatin—esophageal cancer	0.00216	0.00455	CcSEcCtD
Fenofibrate—Abnormal vision—Capecitabine—esophageal cancer	0.00214	0.0045	CcSEcCtD
Fenofibrate—Ear pain—Capecitabine—esophageal cancer	0.00209	0.00439	CcSEcCtD
Fenofibrate—Phlebitis—Capecitabine—esophageal cancer	0.00207	0.00435	CcSEcCtD
Fenofibrate—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00205	0.00431	CcSEcCtD
Fenofibrate—Pancreatitis—Cisplatin—esophageal cancer	0.00205	0.00431	CcSEcCtD
Fenofibrate—Photosensitivity—Capecitabine—esophageal cancer	0.00203	0.00427	CcSEcCtD
Fenofibrate—Bone disorder—Methotrexate—esophageal cancer	0.00202	0.00425	CcSEcCtD
Fenofibrate—Gastroenteritis—Capecitabine—esophageal cancer	0.00201	0.00423	CcSEcCtD
Fenofibrate—Herpes simplex—Methotrexate—esophageal cancer	0.00198	0.00417	CcSEcCtD
Fenofibrate—Hyperuricaemia—Methotrexate—esophageal cancer	0.00197	0.00414	CcSEcCtD
Fenofibrate—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00193	0.00406	CcSEcCtD
Fenofibrate—Renal failure acute—Capecitabine—esophageal cancer	0.00193	0.00406	CcSEcCtD
Fenofibrate—Libido decreased—Capecitabine—esophageal cancer	0.00192	0.00404	CcSEcCtD
Fenofibrate—Increased appetite—Capecitabine—esophageal cancer	0.0019	0.00399	CcSEcCtD
Fenofibrate—Atrial fibrillation—Capecitabine—esophageal cancer	0.00188	0.00395	CcSEcCtD
Fenofibrate—Renal impairment—Capecitabine—esophageal cancer	0.00187	0.00394	CcSEcCtD
Fenofibrate—Dermatitis bullous—Capecitabine—esophageal cancer	0.00187	0.00392	CcSEcCtD
Fenofibrate—Blood uric acid increased—Methotrexate—esophageal cancer	0.00186	0.00391	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00184	0.00386	CcSEcCtD
Fenofibrate—Arthritis—Capecitabine—esophageal cancer	0.00183	0.00386	CcSEcCtD
Fenofibrate—Renal failure—Cisplatin—esophageal cancer	0.00183	0.00385	CcSEcCtD
Fenofibrate—Pulmonary embolism—Methotrexate—esophageal cancer	0.00183	0.00384	CcSEcCtD
Fenofibrate—Myocardial infarction—Cisplatin—esophageal cancer	0.00183	0.00384	CcSEcCtD
Fenofibrate—Conjunctivitis—Cisplatin—esophageal cancer	0.00181	0.00381	CcSEcCtD
Fenofibrate—Cystitis noninfective—Methotrexate—esophageal cancer	0.00179	0.00375	CcSEcCtD
Fenofibrate—Pain in extremity—Capecitabine—esophageal cancer	0.00178	0.00375	CcSEcCtD
Fenofibrate—Osteoarthritis—Capecitabine—esophageal cancer	0.00178	0.00375	CcSEcCtD
Fenofibrate—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00177	0.00372	CcSEcCtD
Fenofibrate—Cystitis—Methotrexate—esophageal cancer	0.00177	0.00371	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00176	0.00371	CcSEcCtD
Fenofibrate—Migraine—Capecitabine—esophageal cancer	0.00175	0.00369	CcSEcCtD
Fenofibrate—Blood creatinine increased—Capecitabine—esophageal cancer	0.00167	0.00351	CcSEcCtD
Fenofibrate—Bladder pain—Methotrexate—esophageal cancer	0.00165	0.00347	CcSEcCtD
Fenofibrate—Ecchymosis—Methotrexate—esophageal cancer	0.00165	0.00347	CcSEcCtD
Fenofibrate—Liver function test abnormal—Capecitabine—esophageal cancer	0.00165	0.00346	CcSEcCtD
Fenofibrate—Connective tissue disorder—Cisplatin—esophageal cancer	0.00164	0.00346	CcSEcCtD
Fenofibrate—Gynaecomastia—Methotrexate—esophageal cancer	0.00164	0.00344	CcSEcCtD
Fenofibrate—Visual impairment—Cisplatin—esophageal cancer	0.00161	0.00339	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00161	0.00337	CcSEcCtD
Fenofibrate—Nasopharyngitis—Capecitabine—esophageal cancer	0.00159	0.00335	CcSEcCtD
Fenofibrate—Gastritis—Capecitabine—esophageal cancer	0.00158	0.00332	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00157	0.00331	CcSEcCtD
Fenofibrate—Muscular weakness—Capecitabine—esophageal cancer	0.00157	0.00331	CcSEcCtD
Fenofibrate—Eye disorder—Cisplatin—esophageal cancer	0.00156	0.00329	CcSEcCtD
Fenofibrate—Lymphadenopathy—Methotrexate—esophageal cancer	0.00156	0.00327	CcSEcCtD
Fenofibrate—Cardiac disorder—Cisplatin—esophageal cancer	0.00155	0.00326	CcSEcCtD
Fenofibrate—Influenza—Capecitabine—esophageal cancer	0.00154	0.00324	CcSEcCtD
Fenofibrate—Asthma—Capecitabine—esophageal cancer	0.00154	0.00324	CcSEcCtD
Fenofibrate—Photosensitivity—Methotrexate—esophageal cancer	0.00151	0.00318	CcSEcCtD
Fenofibrate—Mediastinal disorder—Cisplatin—esophageal cancer	0.00151	0.00317	CcSEcCtD
Fenofibrate—Angina pectoris—Capecitabine—esophageal cancer	0.0015	0.00315	CcSEcCtD
Fenofibrate—Arrhythmia—Cisplatin—esophageal cancer	0.00149	0.00314	CcSEcCtD
Fenofibrate—Bronchitis—Capecitabine—esophageal cancer	0.00148	0.00311	CcSEcCtD
Fenofibrate—Alopecia—Cisplatin—esophageal cancer	0.00148	0.00311	CcSEcCtD
Fenofibrate—Malnutrition—Cisplatin—esophageal cancer	0.00146	0.00306	CcSEcCtD
Fenofibrate—Erythema—Cisplatin—esophageal cancer	0.00146	0.00306	CcSEcCtD
Fenofibrate—Dysuria—Capecitabine—esophageal cancer	0.00144	0.00303	CcSEcCtD
Fenofibrate—Renal failure acute—Methotrexate—esophageal cancer	0.00144	0.00302	CcSEcCtD
Fenofibrate—Flatulence—Cisplatin—esophageal cancer	0.00143	0.00302	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00143	0.00301	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00141	0.00296	CcSEcCtD
Fenofibrate—Weight increased—Capecitabine—esophageal cancer	0.0014	0.00295	CcSEcCtD
Fenofibrate—Muscle spasms—Cisplatin—esophageal cancer	0.0014	0.00294	CcSEcCtD
Fenofibrate—Weight decreased—Capecitabine—esophageal cancer	0.00139	0.00293	CcSEcCtD
Fenofibrate—Pneumonia—Capecitabine—esophageal cancer	0.00138	0.0029	CcSEcCtD
Fenofibrate—Infestation—Capecitabine—esophageal cancer	0.00137	0.00289	CcSEcCtD
Fenofibrate—Infestation NOS—Capecitabine—esophageal cancer	0.00137	0.00289	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00135	0.00285	CcSEcCtD
Fenofibrate—Ill-defined disorder—Cisplatin—esophageal cancer	0.00135	0.00284	CcSEcCtD
Fenofibrate—Renal failure—Capecitabine—esophageal cancer	0.00135	0.00284	CcSEcCtD
Fenofibrate—Myocardial infarction—Capecitabine—esophageal cancer	0.00135	0.00283	CcSEcCtD
Fenofibrate—Anaemia—Cisplatin—esophageal cancer	0.00135	0.00283	CcSEcCtD
Fenofibrate—Jaundice—Capecitabine—esophageal cancer	0.00134	0.00281	CcSEcCtD
Fenofibrate—Conjunctivitis—Capecitabine—esophageal cancer	0.00134	0.00281	CcSEcCtD
Fenofibrate—Urinary tract infection—Capecitabine—esophageal cancer	0.00134	0.00281	CcSEcCtD
Fenofibrate—Osteoarthritis—Methotrexate—esophageal cancer	0.00133	0.00279	CcSEcCtD
Fenofibrate—Indomethacin—PTGS2—esophageal cancer	0.00132	0.0461	CrCbGaD
Fenofibrate—Malaise—Cisplatin—esophageal cancer	0.00131	0.00276	CcSEcCtD
Fenofibrate—Leukopenia—Cisplatin—esophageal cancer	0.0013	0.00274	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Capecitabine—esophageal cancer	0.0013	0.00273	CcSEcCtD
Fenofibrate—Myalgia—Cisplatin—esophageal cancer	0.00124	0.00261	CcSEcCtD
Fenofibrate—Rhinitis—Capecitabine—esophageal cancer	0.00124	0.0026	CcSEcCtD
Fenofibrate—Anxiety—Cisplatin—esophageal cancer	0.00124	0.0026	CcSEcCtD
Fenofibrate—Hepatitis—Capecitabine—esophageal cancer	0.00123	0.00259	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00123	0.00259	CcSEcCtD
Fenofibrate—Liver function test abnormal—Methotrexate—esophageal cancer	0.00123	0.00258	CcSEcCtD
Fenofibrate—Discomfort—Cisplatin—esophageal cancer	0.00122	0.00258	CcSEcCtD
Fenofibrate—Pharyngitis—Capecitabine—esophageal cancer	0.00122	0.00257	CcSEcCtD
Fenofibrate—Oedema peripheral—Capecitabine—esophageal cancer	0.00121	0.00255	CcSEcCtD
Fenofibrate—Connective tissue disorder—Capecitabine—esophageal cancer	0.00121	0.00255	CcSEcCtD
Fenofibrate—Oedema—Cisplatin—esophageal cancer	0.00119	0.0025	CcSEcCtD
Fenofibrate—Visual impairment—Capecitabine—esophageal cancer	0.00119	0.0025	CcSEcCtD
Fenofibrate—Infection—Cisplatin—esophageal cancer	0.00118	0.00248	CcSEcCtD
Fenofibrate—Nervous system disorder—Cisplatin—esophageal cancer	0.00117	0.00245	CcSEcCtD
Fenofibrate—Thrombocytopenia—Cisplatin—esophageal cancer	0.00116	0.00245	CcSEcCtD
Fenofibrate—Tachycardia—Cisplatin—esophageal cancer	0.00116	0.00244	CcSEcCtD
Fenofibrate—Skin disorder—Cisplatin—esophageal cancer	0.00115	0.00243	CcSEcCtD
Fenofibrate—Eye disorder—Capecitabine—esophageal cancer	0.00115	0.00242	CcSEcCtD
Fenofibrate—Hyperhidrosis—Cisplatin—esophageal cancer	0.00115	0.00242	CcSEcCtD
Fenofibrate—Asthma—Methotrexate—esophageal cancer	0.00115	0.00241	CcSEcCtD
Fenofibrate—Cardiac disorder—Capecitabine—esophageal cancer	0.00114	0.00241	CcSEcCtD
Fenofibrate—Eosinophilia—Methotrexate—esophageal cancer	0.00114	0.00239	CcSEcCtD
Fenofibrate—Anorexia—Cisplatin—esophageal cancer	0.00113	0.00238	CcSEcCtD
Fenofibrate—Pancreatitis—Methotrexate—esophageal cancer	0.00112	0.00236	CcSEcCtD
Fenofibrate—Indomethacin—ABCB1—esophageal cancer	0.00112	0.0392	CrCbGaD
Fenofibrate—Angiopathy—Capecitabine—esophageal cancer	0.00112	0.00235	CcSEcCtD
Fenofibrate—Mediastinal disorder—Capecitabine—esophageal cancer	0.00111	0.00234	CcSEcCtD
Fenofibrate—Hypotension—Cisplatin—esophageal cancer	0.00111	0.00233	CcSEcCtD
Fenofibrate—Arrhythmia—Capecitabine—esophageal cancer	0.0011	0.00232	CcSEcCtD
Fenofibrate—Alopecia—Capecitabine—esophageal cancer	0.00109	0.00229	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00108	0.00228	CcSEcCtD
Fenofibrate—Mental disorder—Capecitabine—esophageal cancer	0.00108	0.00227	CcSEcCtD
Fenofibrate—Erythema—Capecitabine—esophageal cancer	0.00107	0.00226	CcSEcCtD
Fenofibrate—Malnutrition—Capecitabine—esophageal cancer	0.00107	0.00226	CcSEcCtD
Fenofibrate—Dysuria—Methotrexate—esophageal cancer	0.00107	0.00225	CcSEcCtD
Fenofibrate—Paraesthesia—Cisplatin—esophageal cancer	0.00107	0.00224	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00107	0.00224	CcSEcCtD
Fenofibrate—Dyspnoea—Cisplatin—esophageal cancer	0.00106	0.00223	CcSEcCtD
Fenofibrate—Flatulence—Capecitabine—esophageal cancer	0.00106	0.00222	CcSEcCtD
Fenofibrate—Erectile dysfunction—Methotrexate—esophageal cancer	0.00106	0.00222	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00105	0.0022	CcSEcCtD
Fenofibrate—Back pain—Capecitabine—esophageal cancer	0.00104	0.00218	CcSEcCtD
Fenofibrate—Decreased appetite—Cisplatin—esophageal cancer	0.00103	0.00217	CcSEcCtD
Fenofibrate—Muscle spasms—Capecitabine—esophageal cancer	0.00103	0.00217	CcSEcCtD
Fenofibrate—Pneumonia—Methotrexate—esophageal cancer	0.00103	0.00216	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00103	0.00216	CcSEcCtD
Fenofibrate—Infestation NOS—Methotrexate—esophageal cancer	0.00102	0.00215	CcSEcCtD
Fenofibrate—Infestation—Methotrexate—esophageal cancer	0.00102	0.00215	CcSEcCtD
Fenofibrate—Pain—Cisplatin—esophageal cancer	0.00102	0.00214	CcSEcCtD
Fenofibrate—Renal failure—Methotrexate—esophageal cancer	0.00101	0.00211	CcSEcCtD
Fenofibrate—Ill-defined disorder—Capecitabine—esophageal cancer	0.000996	0.00209	CcSEcCtD
Fenofibrate—Conjunctivitis—Methotrexate—esophageal cancer	0.000994	0.00209	CcSEcCtD
Fenofibrate—Anaemia—Capecitabine—esophageal cancer	0.000992	0.00209	CcSEcCtD
Fenofibrate—Sweating—Methotrexate—esophageal cancer	0.00098	0.00206	CcSEcCtD
Fenofibrate—Feeling abnormal—Cisplatin—esophageal cancer	0.000979	0.00206	CcSEcCtD
Fenofibrate—Malaise—Capecitabine—esophageal cancer	0.000968	0.00204	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000967	0.00203	CcSEcCtD
Fenofibrate—Vertigo—Capecitabine—esophageal cancer	0.000964	0.00203	CcSEcCtD
Fenofibrate—Leukopenia—Capecitabine—esophageal cancer	0.000961	0.00202	CcSEcCtD
Fenofibrate—Palpitations—Capecitabine—esophageal cancer	0.000949	0.00199	CcSEcCtD
Fenofibrate—Body temperature increased—Cisplatin—esophageal cancer	0.00094	0.00198	CcSEcCtD
Fenofibrate—Cough—Capecitabine—esophageal cancer	0.000937	0.00197	CcSEcCtD
Fenofibrate—Hypertension—Capecitabine—esophageal cancer	0.000927	0.00195	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—esophageal cancer	0.000918	0.00193	CcSEcCtD
Fenofibrate—Chest pain—Capecitabine—esophageal cancer	0.000914	0.00192	CcSEcCtD
Fenofibrate—Myalgia—Capecitabine—esophageal cancer	0.000914	0.00192	CcSEcCtD
Fenofibrate—Arthralgia—Capecitabine—esophageal cancer	0.000914	0.00192	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—esophageal cancer	0.000911	0.00192	CcSEcCtD
Fenofibrate—Anxiety—Capecitabine—esophageal cancer	0.000911	0.00191	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000908	0.00191	CcSEcCtD
Fenofibrate—Discomfort—Capecitabine—esophageal cancer	0.000903	0.0019	CcSEcCtD
Fenofibrate—Dry mouth—Capecitabine—esophageal cancer	0.000894	0.00188	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—esophageal cancer	0.000885	0.00186	CcSEcCtD
Fenofibrate—Oedema—Capecitabine—esophageal cancer	0.000876	0.00184	CcSEcCtD
Fenofibrate—Hypersensitivity—Cisplatin—esophageal cancer	0.000876	0.00184	CcSEcCtD
Fenofibrate—Infection—Capecitabine—esophageal cancer	0.00087	0.00183	CcSEcCtD
Fenofibrate—Nervous system disorder—Capecitabine—esophageal cancer	0.000859	0.00181	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—esophageal cancer	0.000858	0.0018	CcSEcCtD
Fenofibrate—Thrombocytopenia—Capecitabine—esophageal cancer	0.000858	0.0018	CcSEcCtD
Fenofibrate—Tachycardia—Capecitabine—esophageal cancer	0.000855	0.0018	CcSEcCtD
Fenofibrate—Asthenia—Cisplatin—esophageal cancer	0.000853	0.00179	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—esophageal cancer	0.000852	0.00179	CcSEcCtD
Fenofibrate—Skin disorder—Capecitabine—esophageal cancer	0.000851	0.00179	CcSEcCtD
Fenofibrate—Hyperhidrosis—Capecitabine—esophageal cancer	0.000847	0.00178	CcSEcCtD
Fenofibrate—Anorexia—Capecitabine—esophageal cancer	0.000835	0.00176	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—esophageal cancer	0.000833	0.00175	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—esophageal cancer	0.000827	0.00174	CcSEcCtD
Fenofibrate—Hypotension—Capecitabine—esophageal cancer	0.000819	0.00172	CcSEcCtD
Fenofibrate—Diarrhoea—Cisplatin—esophageal cancer	0.000813	0.00171	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—esophageal cancer	0.000811	0.00171	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—esophageal cancer	0.000804	0.00169	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—esophageal cancer	0.000799	0.00168	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—esophageal cancer	0.000799	0.00168	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000798	0.00168	CcSEcCtD
Fenofibrate—Insomnia—Capecitabine—esophageal cancer	0.000792	0.00167	CcSEcCtD
Fenofibrate—Paraesthesia—Capecitabine—esophageal cancer	0.000787	0.00165	CcSEcCtD
Fenofibrate—Dyspnoea—Capecitabine—esophageal cancer	0.000781	0.00164	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—esophageal cancer	0.000773	0.00163	CcSEcCtD
Fenofibrate—Dyspepsia—Capecitabine—esophageal cancer	0.000771	0.00162	CcSEcCtD
Fenofibrate—Decreased appetite—Capecitabine—esophageal cancer	0.000762	0.0016	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000756	0.00159	CcSEcCtD
Fenofibrate—Vomiting—Cisplatin—esophageal cancer	0.000756	0.00159	CcSEcCtD
Fenofibrate—Fatigue—Capecitabine—esophageal cancer	0.000755	0.00159	CcSEcCtD
Fenofibrate—Rash—Cisplatin—esophageal cancer	0.000749	0.00158	CcSEcCtD
Fenofibrate—Pain—Capecitabine—esophageal cancer	0.000749	0.00157	CcSEcCtD
Fenofibrate—Constipation—Capecitabine—esophageal cancer	0.000749	0.00157	CcSEcCtD
Fenofibrate—Dermatitis—Cisplatin—esophageal cancer	0.000749	0.00157	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—esophageal cancer	0.000741	0.00156	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—esophageal cancer	0.000739	0.00155	CcSEcCtD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.000723	0.00201	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Capecitabine—esophageal cancer	0.000722	0.00152	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—esophageal cancer	0.000721	0.00151	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—esophageal cancer	0.000718	0.00151	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000716	0.00151	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTO1—esophageal cancer	0.000715	0.00199	CbGpPWpGaD
Fenofibrate—Leukopenia—Methotrexate—esophageal cancer	0.000715	0.0015	CcSEcCtD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	0.000715	0.00198	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000715	0.00198	CbGpPWpGaD
Fenofibrate—Nausea—Cisplatin—esophageal cancer	0.000706	0.00148	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTO1—esophageal cancer	0.000706	0.00196	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000701	0.00195	CbGpPWpGaD
Fenofibrate—Cough—Methotrexate—esophageal cancer	0.000697	0.00147	CcSEcCtD
Fenofibrate—Urticaria—Capecitabine—esophageal cancer	0.000696	0.00146	CcSEcCtD
Fenofibrate—Body temperature increased—Capecitabine—esophageal cancer	0.000693	0.00146	CcSEcCtD
Fenofibrate—Abdominal pain—Capecitabine—esophageal cancer	0.000693	0.00146	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—SMG6—esophageal cancer	0.000689	0.00191	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—SLC52A3—esophageal cancer	0.000689	0.00191	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—BLVRB—esophageal cancer	0.000689	0.00191	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000683	0.0019	CbGpPWpGaD
Fenofibrate—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000681	0.00189	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000681	0.00189	CbGpPWpGaD
Fenofibrate—Myalgia—Methotrexate—esophageal cancer	0.00068	0.00143	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—esophageal cancer	0.00068	0.00143	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—esophageal cancer	0.00068	0.00143	CcSEcCtD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000677	0.00188	CbGpPWpGaD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000676	0.00142	CcSEcCtD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000674	0.00187	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.000674	0.00187	CbGpPWpGaD
Fenofibrate—Discomfort—Methotrexate—esophageal cancer	0.000672	0.00141	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—CDKN1A—esophageal cancer	0.000672	0.00186	CbGpPWpGaD
Fenofibrate—Infection—Methotrexate—esophageal cancer	0.000648	0.00136	CcSEcCtD
Fenofibrate—Hypersensitivity—Capecitabine—esophageal cancer	0.000645	0.00136	CcSEcCtD
Fenofibrate—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000641	0.00178	CbGpPWpGaD
Fenofibrate—Nervous system disorder—Methotrexate—esophageal cancer	0.00064	0.00134	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—esophageal cancer	0.000639	0.00134	CcSEcCtD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000637	0.00177	CbGpPWpGaD
Fenofibrate—Skin disorder—Methotrexate—esophageal cancer	0.000633	0.00133	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—esophageal cancer	0.00063	0.00133	CcSEcCtD
Fenofibrate—Asthenia—Capecitabine—esophageal cancer	0.000629	0.00132	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000626	0.00174	CbGpPWpGaD
Fenofibrate—Anorexia—Methotrexate—esophageal cancer	0.000622	0.00131	CcSEcCtD
Fenofibrate—Pruritus—Capecitabine—esophageal cancer	0.00062	0.0013	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000618	0.00171	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000616	0.00171	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000611	0.00169	CbGpPWpGaD
Fenofibrate—Hypotension—Methotrexate—esophageal cancer	0.000609	0.00128	CcSEcCtD
Fenofibrate—Diarrhoea—Capecitabine—esophageal cancer	0.000599	0.00126	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000594	0.00125	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—esophageal cancer	0.00059	0.00124	CcSEcCtD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000589	0.00164	CbGpPWpGaD
Fenofibrate—Paraesthesia—Methotrexate—esophageal cancer	0.000586	0.00123	CcSEcCtD
Fenofibrate—PPARA—Metabolism—SLC10A2—esophageal cancer	0.000585	0.00163	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CA1—esophageal cancer	0.000585	0.00163	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—ALDH2—esophageal cancer	0.000583	0.00162	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000582	0.00162	CbGpPWpGaD
Fenofibrate—Dyspnoea—Methotrexate—esophageal cancer	0.000581	0.00122	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—esophageal cancer	0.00058	0.00122	CcSEcCtD
Fenofibrate—Dizziness—Capecitabine—esophageal cancer	0.000579	0.00122	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000574	0.00159	CbGpPWpGaD
Fenofibrate—Dyspepsia—Methotrexate—esophageal cancer	0.000574	0.00121	CcSEcCtD
Fenofibrate—Decreased appetite—Methotrexate—esophageal cancer	0.000567	0.00119	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000563	0.00118	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—esophageal cancer	0.000562	0.00118	CcSEcCtD
Fenofibrate—Pain—Methotrexate—esophageal cancer	0.000558	0.00117	CcSEcCtD
Fenofibrate—Vomiting—Capecitabine—esophageal cancer	0.000557	0.00117	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTT1—esophageal cancer	0.000555	0.00154	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000554	0.00154	CbGpPWpGaD
Fenofibrate—Rash—Capecitabine—esophageal cancer	0.000552	0.00116	CcSEcCtD
Fenofibrate—Dermatitis—Capecitabine—esophageal cancer	0.000552	0.00116	CcSEcCtD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000551	0.00153	CbGpPWpGaD
Fenofibrate—Headache—Capecitabine—esophageal cancer	0.000549	0.00115	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—CYP2A6—esophageal cancer	0.000548	0.00152	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000544	0.00151	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Methotrexate—esophageal cancer	0.000537	0.00113	CcSEcCtD
Fenofibrate—PPARA—Metabolism—CA2—esophageal cancer	0.000535	0.00149	CbGpPWpGaD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000535	0.00149	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000533	0.00112	CcSEcCtD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000525	0.00146	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000523	0.00145	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—NR1I2—esophageal cancer	0.000522	0.00145	CbGpPWpGaD
Fenofibrate—Nausea—Capecitabine—esophageal cancer	0.00052	0.00109	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—PTGS1—esophageal cancer	0.00052	0.00144	CbGpPWpGaD
Fenofibrate—Urticaria—Methotrexate—esophageal cancer	0.000518	0.00109	CcSEcCtD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000518	0.00144	CbGpPWpGaD
Fenofibrate—Abdominal pain—Methotrexate—esophageal cancer	0.000516	0.00108	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—esophageal cancer	0.000516	0.00108	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000513	0.00142	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000511	0.00142	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000507	0.00141	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—ABL1—esophageal cancer	0.000498	0.00138	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ADH7—esophageal cancer	0.000498	0.00138	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PLCE1—esophageal cancer	0.000498	0.00138	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.000493	0.00137	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000492	0.00137	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—SMAD4—esophageal cancer	0.000483	0.00134	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Methotrexate—esophageal cancer	0.000481	0.00101	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000475	0.00132	CbGpPWpGaD
Fenofibrate—Asthenia—Methotrexate—esophageal cancer	0.000468	0.000984	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—esophageal cancer	0.000461	0.00097	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000451	0.00125	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—EP300—esophageal cancer	0.000451	0.00125	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—HIST1H2BM—esophageal cancer	0.000448	0.00124	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000447	0.00124	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000446	0.00124	CbGpPWpGaD
Fenofibrate—Diarrhoea—Methotrexate—esophageal cancer	0.000446	0.000938	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000444	0.00123	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP1B1—esophageal cancer	0.000442	0.00123	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ADH1B—esophageal cancer	0.000437	0.00121	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000436	0.00121	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000436	0.00121	CbGpPWpGaD
Fenofibrate—Dizziness—Methotrexate—esophageal cancer	0.000431	0.000907	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000427	0.00119	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000426	0.00118	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000423	0.00117	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00042	0.00117	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—TYMP—esophageal cancer	0.000417	0.00116	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP19A1—esophageal cancer	0.000416	0.00115	CbGpPWpGaD
Fenofibrate—Vomiting—Methotrexate—esophageal cancer	0.000415	0.000872	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000413	0.00115	CbGpPWpGaD
Fenofibrate—Rash—Methotrexate—esophageal cancer	0.000411	0.000864	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—esophageal cancer	0.000411	0.000864	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00041	0.00114	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00041	0.00114	CbGpPWpGaD
Fenofibrate—Headache—Methotrexate—esophageal cancer	0.000409	0.000859	CcSEcCtD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000407	0.00113	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP26A1—esophageal cancer	0.000406	0.00113	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ALOX15—esophageal cancer	0.000395	0.0011	CbGpPWpGaD
Fenofibrate—Nausea—Methotrexate—esophageal cancer	0.000387	0.000814	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000384	0.00107	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000379	0.00105	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000378	0.00105	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—KDR—esophageal cancer	0.000378	0.00105	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—TPI1—esophageal cancer	0.000377	0.00105	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTO1—esophageal cancer	0.000377	0.00105	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MET—esophageal cancer	0.00037	0.00103	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ALDOB—esophageal cancer	0.000362	0.001	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.00036	0.000998	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—NOTCH1—esophageal cancer	0.000356	0.000987	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000355	0.000985	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GAPDH—esophageal cancer	0.000348	0.000966	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—PSME2—esophageal cancer	0.000347	0.000964	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—PSME1—esophageal cancer	0.000347	0.000964	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000347	0.000963	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CRABP1—esophageal cancer	0.000345	0.000958	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000343	0.000951	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000338	0.000939	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000334	0.000926	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GNG7—esophageal cancer	0.000328	0.000911	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—NOTCH3—esophageal cancer	0.000328	0.00091	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—esophageal cancer	0.000323	0.000896	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CREBBP—esophageal cancer	0.000323	0.000895	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000313	0.000869	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ALDH2—esophageal cancer	0.000308	0.000854	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000298	0.000826	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000294	0.000817	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—NOTCH2—esophageal cancer	0.000294	0.000816	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTT1—esophageal cancer	0.000293	0.000812	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP2A6—esophageal cancer	0.000289	0.000803	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000288	0.0008	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000288	0.000799	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000279	0.000774	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ENO1—esophageal cancer	0.000274	0.000761	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS1—esophageal cancer	0.000274	0.000761	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000274	0.00076	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PSME1—esophageal cancer	0.00027	0.00075	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PSME2—esophageal cancer	0.00027	0.00075	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—ERBB2—esophageal cancer	0.00027	0.00075	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000251	0.000697	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—SMAD4—esophageal cancer	0.000247	0.000685	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000237	0.000659	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000236	0.000655	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000234	0.000651	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000234	0.000649	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP1B1—esophageal cancer	0.000233	0.000647	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—BLVRB—esophageal cancer	0.000223	0.00062	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC52A3—esophageal cancer	0.000223	0.00062	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000223	0.000619	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00022	0.000611	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EP300—esophageal cancer	0.00022	0.00061	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP19A1—esophageal cancer	0.000219	0.000608	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000204	0.000568	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—MYC—esophageal cancer	0.000203	0.000565	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—HMOX1—esophageal cancer	0.0002	0.000555	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.0002	0.000554	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000196	0.000545	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ABCB1—esophageal cancer	0.000192	0.000533	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC10A2—esophageal cancer	0.00019	0.000527	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CA1—esophageal cancer	0.00019	0.000527	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EGFR—esophageal cancer	0.000187	0.00052	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—NOTCH1—esophageal cancer	0.000182	0.000505	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000182	0.000504	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000182	0.000504	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CA2—esophageal cancer	0.000174	0.000482	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00017	0.000471	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—CREBBP—esophageal cancer	0.000165	0.000458	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000162	0.000451	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ADH7—esophageal cancer	0.000161	0.000448	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PLCE1—esophageal cancer	0.000161	0.000448	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00016	0.000443	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000155	0.000429	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CA1—esophageal cancer	0.000155	0.000429	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000145	0.000403	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000142	0.000393	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CA2—esophageal cancer	0.000141	0.000392	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000138	0.000383	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000135	0.000376	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP26A1—esophageal cancer	0.000132	0.000365	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000131	0.000365	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000131	0.000365	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00013	0.00036	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CREBBP—esophageal cancer	0.000128	0.000356	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALOX15—esophageal cancer	0.000128	0.000356	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTO1—esophageal cancer	0.000122	0.00034	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TPI1—esophageal cancer	0.000122	0.00034	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.00012	0.000333	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.00012	0.000333	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALDOB—esophageal cancer	0.000117	0.000326	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000115	0.00032	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NOS3—esophageal cancer	0.000115	0.000319	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GAPDH—esophageal cancer	0.000113	0.000313	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CRABP1—esophageal cancer	0.000112	0.000311	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TYMP—esophageal cancer	0.00011	0.000306	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000107	0.000297	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GNG7—esophageal cancer	0.000106	0.000295	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS2—esophageal cancer	0.000105	0.000292	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000104	0.00029	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CA1—esophageal cancer	0.000102	0.000283	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000102	0.000283	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALDH2—esophageal cancer	9.97e-05	0.000277	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TPI1—esophageal cancer	9.96e-05	0.000276	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.96e-05	0.000276	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MYC—esophageal cancer	9.79e-05	0.000272	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.55e-05	0.000265	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTT1—esophageal cancer	9.49e-05	0.000263	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP2A6—esophageal cancer	9.38e-05	0.00026	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.34e-05	0.000259	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CA2—esophageal cancer	9.32e-05	0.000259	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.19e-05	0.000255	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.11e-05	0.000253	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ENO1—esophageal cancer	8.89e-05	0.000247	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS1—esophageal cancer	8.89e-05	0.000247	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PSME1—esophageal cancer	8.76e-05	0.000243	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PSME2—esophageal cancer	8.76e-05	0.000243	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—EP300—esophageal cancer	8.74e-05	0.000243	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ADH7—esophageal cancer	8.66e-05	0.000241	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.66e-05	0.000241	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GNG7—esophageal cancer	8.66e-05	0.00024	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.12e-05	0.000225	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.72e-05	0.000214	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.65e-05	0.000212	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.63e-05	0.000212	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.6e-05	0.000211	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.6e-05	0.000211	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP1B1—esophageal cancer	7.56e-05	0.00021	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TYMP—esophageal cancer	7.26e-05	0.000202	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.23e-05	0.000201	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ENO1—esophageal cancer	7.23e-05	0.000201	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PSME2—esophageal cancer	7.13e-05	0.000198	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PSME1—esophageal cancer	7.13e-05	0.000198	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP19A1—esophageal cancer	7.11e-05	0.000197	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.06e-05	0.000196	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.88e-05	0.000191	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.57e-05	0.000182	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TPI1—esophageal cancer	6.57e-05	0.000182	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HMOX1—esophageal cancer	6.48e-05	0.00018	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CA—esophageal cancer	6.46e-05	0.000179	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.36e-05	0.000177	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.3e-05	0.000175	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.23e-05	0.000173	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ABCB1—esophageal cancer	6.22e-05	0.000173	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.15e-05	0.000171	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.06e-05	0.000168	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.01e-05	0.000167	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.78e-05	0.000161	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GNG7—esophageal cancer	5.71e-05	0.000159	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.35e-05	0.000149	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.28e-05	0.000147	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.18e-05	0.000144	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.09e-05	0.000141	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.07e-05	0.000141	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.03e-05	0.00014	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.77e-05	0.000132	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ENO1—esophageal cancer	4.77e-05	0.000132	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.71e-05	0.000131	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PSME1—esophageal cancer	4.7e-05	0.000131	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PSME2—esophageal cancer	4.7e-05	0.000131	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CREBBP—esophageal cancer	4.16e-05	0.000115	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.06e-05	0.000113	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.83e-05	0.000106	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.81e-05	0.000106	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NOS3—esophageal cancer	3.72e-05	0.000103	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.48e-05	9.66e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.41e-05	9.46e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.39e-05	9.4e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.34e-05	9.27e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NOS3—esophageal cancer	3.03e-05	8.41e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—EP300—esophageal cancer	2.83e-05	7.86e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.77e-05	7.7e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—EP300—esophageal cancer	2.31e-05	6.4e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.23e-05	6.2e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.1e-05	5.82e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NOS3—esophageal cancer	2e-05	5.55e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.83e-05	5.08e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.71e-05	4.73e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—EP300—esophageal cancer	1.52e-05	4.22e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.12e-05	3.12e-05	CbGpPWpGaD
